Clinical impact of dose overestimation by effective path length calculation in stereotactic ablative radiation therapy of lung tumors

Clinical follow-up for local lung tumor control in a sizable cohort of patients treated with SABR demonstrates that EPL overestimates dose by amounts that substantially decrease TCP in a large proportion. EPL algorithms should be avoided for lung tumor SABR.